AlphaGen
Access AlphaGen
Company Narratives

Nimir Industrial Chemicals FY2026: Q4 Margin Rebound Meets a Heavier Working-Capital Bill

Nimir’s FY2026 margins and pre-tax profit improved sharply, but inventory and receivables weakened cash conversion as Q4 strengthened and tax limited PAT growth.

Sep 17, 2026

Verdict: Nimir Industrial Chemicals closed FY2026 with a materially better operating finish than its full-year profit-after-tax growth alone suggests. Audited net revenue rose 6.7% to PKR 48.29 billion, gross profit increased 13.5% and operating profit rose 16.3%, while finance cost fell 23.6%. Profit before income tax and levy consequently advanced 63.7% to PKR 4.49 billion. Profit after tax grew a more modest 18.3% to PKR 2.39 billion because the tax burden increased sharply. The derived fourth quarter was particularly strong at gross and operating level, but the quality of FY2026 earnings is tempered by a large working-capital build: inventory and receivables absorbed cash, operating cash flow fell, and short-term borrowing increased. That makes the next cycle less about whether accounting profit can grow and more about whether improved margins convert into cash while the company starts a new PKR 3.0 billion investment programme.

Results at a glance

Company Name: Nimir Industrial Chemicals Limited

Ticker: NICL

Reporting period: year ended June 30, 2026. The current PSX result presents audited company financial statements. PSX lists the September 9 result entry as revoked and the September 10 result as the current announcement; this analysis follows the current filing.

Alpha QoQ Score: 99.76

TTM Performance Score: 99.74

3Y Business Perf Score: 72.91

Sector Leadership Score: 48.10

These four scores are AlphaGen model outputs, not company-reported figures.

What improved

The clearest improvement was the gross spread. Full-year cost of revenue increased about 5.5%, slower than the 6.7% rise in net revenue, allowing gross profit to grow faster than sales and lifting gross margin by about 0.94 percentage point. That improvement is notable because management’s nine-month commentary described a difficult input backdrop: conflict in the Middle East had raised crude-oil and related commodity prices and increased supply-chain risks, while profitability was being squeezed despite higher turnover. FY2026 therefore ended better than the March run rate implied.

The derived Q4 bridge makes that improvement clearer. Q4 net revenue was about PKR 13.38 billion versus PKR 12.67 billion a year earlier, but gross profit rose to roughly PKR 2.52 billion from PKR 1.60 billion. That implies a derived Q4 gross margin of about 18.83% versus 12.61%. Operating profit was approximately PKR 2.19 billion, up about 74%, and the derived operating margin expanded to about 16.36% from 9.94%. Because the detailed FY2026 annual report and operating notes are not yet available in the result package, the exact split among selling prices, product mix, input costs and utilization cannot be established from public evidence; assigning the rebound to any one factor would therefore be inference.

Finance cost provided another major tailwind, falling to PKR 1.80 billion from PKR 2.36 billion despite a still-large financing base. A lower average benchmark-rate environment likely contributed, although this is an inference because the result package does not isolate the effects of rates, debt mix and utilization. SBP had reduced the policy rate to 10.5% in December 2025 before raising it to 11.5% effective April 28, 2026. The benefit visible in FY2026 should therefore not be extrapolated mechanically into the next year.

Below operating profit, other income more than doubled to PKR 365.5 million while other expense declined to PKR 350.9 million. The cash-flow reconciliation also identifies sizeable non-cash or settlement-related items, including approximately PKR 495.2 million of long-term-payable waiver/settlement, PKR 180.2 million related to other payables and PKR 188.3 million for recognition of an RLNG liability. Without the detailed annual notes, those reconciliation items should not be mapped mechanically to individual income-statement captions; their presence is a reason to distinguish clean recurring performance from accounting and settlement effects.

What weakened / needs attention

Cash conversion weakened even as accounting profit improved. Net cash generated from operating activities fell to PKR 1.36 billion from PKR 1.75 billion, a decline of about 22%. Cash generated from operations before financing and tax payments was PKR 3.76 billion versus PKR 5.02 billion. The main issue was working capital rather than the income statement.

The working-capital movement was a PKR 3.34 billion cash outflow compared with only PKR 0.59 billion a year earlier. Stock-in-trade absorbed roughly PKR 2.33 billion and trade receivables absorbed about PKR 1.10 billion. At June 30, inventory stood at PKR 10.75 billion, up 27.7%, and trade receivables at PKR 8.91 billion, up 14.1%. Together those two balances tied up nearly PKR 19.66 billion, so sustaining the earnings improvement without further balance-sheet expansion is an important next-cycle test.

Liquidity improved modestly on the face of the balance sheet: current assets rose to PKR 22.31 billion against PKR 19.40 billion of current liabilities, implying a current ratio near 1.15 versus roughly 1.05 a year earlier. Cash was only PKR 209 million, however, while short-term borrowings increased 9.9% to PKR 14.28 billion. Long-term loans declined 27.4% to PKR 2.38 billion and the current portion of non-current liabilities also fell. Debt-like obligations were therefore broadly stable in aggregate, but the mix remained heavily short term, keeping working-capital efficiency and refinancing conditions important.

Tax was the main reason the surge in pre-tax profit did not translate proportionately into PAT. FY2026 recorded PKR 2.09 billion of income tax and no separate levy, whereas FY2025 carried about PKR 625 million of levy plus PKR 93 million of tax. Measured against profit before income tax and levy, the combined tax-and-levy burden rose to roughly 46.7% from 26.2%. The March 2026 interim report also disclosed a PKR 176 million prior-year super-tax charge following a court decision, illustrating how tax items materially affected the year.

The Q4 comparison reinforces that point. On the annual-minus-nine-month bridge, FY2026 Q4 profit before tax after levy was about PKR 1.88 billion, with roughly PKR 831 million of tax, producing PAT near PKR 1.05 billion. The comparable FY2025 bridge is unusual: after the levy, derived Q4 profit before tax was slightly negative, while a large tax credit lifted PAT to about PKR 680 million. That means the underlying pre-tax improvement in the latest Q4 was much stronger than the roughly 55% PAT growth suggests, and the prior-year Q4 PAT should not be treated as a clean recurring earnings base.

A stronger Q4, but not a broad chemicals boom

Pakistan Bureau of Statistics data show overall large-scale manufacturing grew 4.98% in July–June FY2026, but the chemicals sector declined 2.53% and chemical products fell 3.51%; chemical-products output was also down year on year in June. Nimir’s 6.7% revenue growth is not directly comparable with production indices because revenue also reflects selling prices and mix, but the sector data make one point clear: Nimir’s sales and margin improvement did not occur against a broad-based chemical-production boom.

Peer evidence was mixed rather than uniformly strong. Sitara Chemical’s March-quarter filing showed higher sales and higher profit year on year, while Ittehad Chemicals reported higher sales but lower profit in its comparable quarter. Product portfolios differ, so this is not a like-for-like benchmark. Still, together with the PBS data, it argues against attributing Nimir’s Q4 margin rebound solely to an industry-wide upswing; company-specific pricing, mix, procurement and execution likely mattered, although the exact contribution of each remains an inference until fuller annual disclosures are available.

Historical pattern: recovery continued, but the composition changed

PSX’s multi-year financial history shows net sales moving from about PKR 43.83 billion in FY2023 to PKR 41.93 billion in FY2024, PKR 45.26 billion in FY2025 and PKR 48.29 billion in FY2026. PAT moved from roughly PKR 1.84 billion to PKR 1.00 billion, PKR 2.02 billion and PKR 2.39 billion over the same sequence. FY2026 therefore extended the profit recovery and took sales to a four-year high, but the latest year also showed greater dependence on finance-cost relief, tax outcomes and working-capital funding in the bridge from operating profit to cash.

Recurring versus exceptional drivers

More recurring / operational: full-year gross-margin improvement, the stronger derived Q4 gross spread, revenue growth, financing costs on a large borrowing base, and the continuing need to fund inventory and receivables.

Less recurring / timing-sensitive: the payable waivers and settlement items visible in the cash-flow reconciliation, RLNG-liability recognition, changes in levy and tax treatment, and the unusual tax support embedded in the prior-year derived Q4 comparison.

Dividends and post-period strategic developments

The board proposed a PKR 2.00 final dividend on top of PKR 4.00 already paid as interim dividends. Cash dividends paid during FY2026 were about PKR 661.6 million versus PKR 551.6 million a year earlier. The payout is meaningful, but the larger strategic issue after year-end is capital deployment.

On September 9, 2026, Nimir disclosed board approval for a new PKR 3.0 billion capital programme covering a palmitic-acid plant, expansion of chlorinated-paraffin-wax and chlorine-liquefaction capacity, and relocation of one oleochemicals plant from Sheikhupura to Hub, Balochistan. Management described palmitic acid as a new business line tied initially to animal nutrition, cited stronger localized demand for chlorinated paraffin wax, and said the Hub move should strengthen the company’s southern-market and sea-export position. The company expects the projects’ benefits from FY2028 onward, so none should be treated as an FY2026 earnings driver.

A separate post-period development came on September 10, when Nimir disclosed receipt of a public announcement of intention from Cherat Cement Company Limited to acquire at least 30% of Nimir’s ordinary shares, stated in the disclosure as at least 33.18 million shares. This is an intention subject to the takeover process and regulatory requirements, not a completed acquisition, and it had no effect on FY2026 operating results.

What to monitor next

  • Whether the derived Q4 gross margin near 18.8% persists once detailed annual disclosures and the first FY2027 quarter provide more evidence on mix and input costs.
  • Whether inventory and receivables normalize enough for operating cash flow to catch up with profit.
  • Short-term borrowing and working-capital funding costs, especially after the policy rate returned to 11.5% before year-end.
  • Tax normalization after a year shaped by super tax, levy differences and unusual prior-period tax comparisons.
  • Execution and funding of the PKR 3.0 billion post-period investment programme, whose stated benefits are expected from FY2028 onward.
  • Progress, terms and regulatory approvals around Cherat Cement’s announced acquisition intention.

Bottom line

FY2026 was a better operating year for Nimir Industrial Chemicals. Sales reached a four-year high, gross and operating margins improved, finance cost fell and the derived Q4 showed a substantial rebound in gross spread and pre-tax profitability. But cash conversion moved in the opposite direction because inventory and receivables absorbed capital, while the tax line muted the translation of strong pre-tax growth into PAT. The next result cycle therefore has two tests: whether the Q4 margin improvement persists, and whether that profitability begins to release rather than consume working capital. The new capex programme adds a longer-term growth option, but its stated benefits sit beyond the immediate FY2027 earnings cycle.

Public source trail

Explore more research

All articles